Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis

SIMPLE SUMMARY: Intravesical immunotherapy with bacillus Calmette–Guerin (BCG) is the standard therapy for high-risk non-muscle invasive bladder cancer. Different BCG strains are currently available and the superiority of any BCG strain over another could not be demonstrated yet. We compared the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Giudice, Francesco, Flammia, Rocco Simone, Chung, Benjamin I., Moschini, Marco, Pradere, Benjamin, Mari, Andrea, Soria, Francesco, Albisinni, Simone, Krajewski, Wojciech, Szydełko, Tomasz, Laukhtina, Ekaterina, D’Andrea, David, Gallioli, Andrea, Mertens, Laura S., Maggi, Martina, Sciarra, Alessandro, Salciccia, Stefano, Ferro, Matteo, Scornajenghi, Carlo Maria, Asero, Vincenzo, Cattarino, Susanna, De Angelis, Mario, Cacciamani, Giovanni E., Autorino, Riccardo, Pandolfo, Savio Domenico, Falagario, Ugo Giovanni, D’Altilia, Nicola, Mancini, Vito, Chirico, Marco, Cinelli, Francesco, Bettocchi, Carlo, Cormio, Luigi, Carrieri, Giuseppe, De Berardinis, Ettore, Busetto, Gian Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869903/
https://www.ncbi.nlm.nih.gov/pubmed/35205635
http://dx.doi.org/10.3390/cancers14040887

Ejemplares similares

Ejemplares similares